Cango Inc. Joins Bitwise Bitcoin Standard Corporations ETF
SHANGHAI, March 17, 2025 /PRNewswire/ — Cango Inc. (NYSE: CANG) (“Cango” or the “Company”), a leading Bitcoin mining company with an... Read more.
Vidu and Aura Productions Announce Partnership to Debut Sci-Fi Series of AI-Generated Anime Shorts
SINGAPORE, March 17, 2025 /PRNewswire/ — Vidu, the flagship product of ShengShu Technology and a pioneer in generative AI video, is partnering with Aura Productions,... Read more.
Intended Purchases of Ordinary Shares in Connection with the Deferred Compensation Plan
NEW YORK, March 17, 2025 /PRNewswire/ — Burford Capital Limited (“Burford”), the leading global finance and asset management firm focused on law,... Read more.
New Episode of Advancements Scheduled to Broadcast on Saturday, March 22, 2025
Learn how developments in technology are helping businesses and individuals soar to new heights. JUPITER, Fla., March 17, 2025 /PRNewswire/ — Tune in to... Read more.
Canaan Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 26, 2025
SINGAPORE, March 17, 2025 /PRNewswire/ — Canaan Inc. (NASDAQ: CAN) (“Canaan” or the “Company”), an innovator in crypto mining, today... Read more.
Tract Bio Announces Publication in Gastroenterology Revealing Potential Therapeutic Targets in the Evolution of Esophageal Adenocarcinoma Identified Using stemECHO™ Cloning Platform
Proprietary discovery platform, stemECHO, clones and characterizes the role of epithelial stem cells in the pathogenesis of inflammation and cancer, identifying... Read more.
Thoma Bravo Makes Strategic Growth Investment in PCMI
MIAMI and CHICAGO, March 17, 2025 /PRNewswire/ — Thoma Bravo, a leading software investment firm, today announced a strategic growth investment in PCMI (“PCMI”... Read more.
TrustRadius Announces 165 Trusted Sellers in B2B
The Trusted Seller verification enables buyers to easily see which vendors have the most up-to-date product information and ethical, transparent review generation... Read more.
Rona Therapeutics Receives IND Clearance from FDA to Initiate Phase 2 Study of RN0361: an APOC3 Targeted siRNA for Management of Hypertriglyceridemia
SHANGHAI, March 17, 2025 /PRNewswire/ — Rona Therapeutics Inc., a global leader in RNA-targeted therapeutics, announced the clearance of an Investigational... Read more.
THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF DOMESTIC LAW OF THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED
Open Market Purchases and Cancellation of 2025 Bonds NEW YORK, March 17, 2025 /PRNewswire/ — Burford Capital Finance LLC (the “Issuer”), a special... Read more.